Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.75 - $3.44 $130,583 - $256,689
-74,619 Reduced 62.47%
44,832 $82,000
Q1 2022

May 16, 2022

BUY
$6.18 - $14.44 $738,207 - $1.72 Million
119,451 New
119,451 $738,000
Q4 2021

Feb 14, 2022

SELL
$7.8 - $14.38 $189,563 - $349,477
-24,303 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$24.17 - $34.28 $587,403 - $833,106
24,303 New
24,303 $694,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $75.8M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.